Holly Greer, BS

Kathy Kenley, MS, CGC

Obstetrical, perinatal, and genetic outcomes associated with nonreportable prenatal cell-free DNA screening results

• Define common reasons for non-reportable cell-free DNA screening results in a prenatal setting
• Compare rates of adverse genetic, obstetric, and perinatal outcomes in the contexts of reportable and non-reportable prenatal cell-free DNA screening results
• Evaluate follow-up recommendations for further genetic evaluation as well as obstetrical and perinatal surveillance and evaluation for patients with non-reportable prenatal cell-free DNA screening results